Shin‐ichi Yaguchi

593 total citations
14 papers, 517 citations indexed

About

Shin‐ichi Yaguchi is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Shin‐ichi Yaguchi has authored 14 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Shin‐ichi Yaguchi's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (2 papers). Shin‐ichi Yaguchi is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (2 papers). Shin‐ichi Yaguchi collaborates with scholars based in Japan, United States and Russia. Shin‐ichi Yaguchi's co-authors include Takao Yamori, Hisashi Yoshimi, Toshiyuki Matsuno, Shuichi Hirono, Yasuhisa Fukui, Kanami Yamazaki, Hiroaki Gouda, Dexin Kong, Toshiharu Narita and Makoto Inaba and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Cell Death and Disease.

In The Last Decade

Shin‐ichi Yaguchi

14 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shin‐ichi Yaguchi Japan	10	371	124	122	67	50	14	517
Hisashi Yoshimi Japan	6	368 1.0×	91 0.7×	110 0.9×	78 1.2×	33 0.7×	7	485
S.H. Rosenberg United States	8	356 1.0×	182 1.5×	62 0.5×	74 1.1×	58 1.2×	12	588
Shishinn Sun United States	11	245 0.7×	107 0.9×	43 0.4×	47 0.7×	67 1.3×	15	474
Roberta Pireddu United States	10	465 1.3×	240 1.9×	96 0.8×	59 0.9×	100 2.0×	14	718
Elena Dneprovskaia United States	10	204 0.5×	57 0.5×	90 0.7×	59 0.9×	83 1.7×	11	408
Chris J. Novotny United States	9	642 1.7×	179 1.4×	131 1.1×	66 1.0×	61 1.2×	10	829
Sharada Kolekar New Zealand	11	296 0.8×	82 0.7×	128 1.0×	79 1.2×	32 0.6×	13	427
Kurt G. Pike United Kingdom	16	633 1.7×	131 1.1×	210 1.7×	45 0.7×	35 0.7×	37	863
Kimberly A. Robell United States	7	254 0.7×	160 1.3×	107 0.9×	118 1.8×	15 0.3×	8	500
Mutsumi Okamura Japan	12	363 1.0×	72 0.6×	75 0.6×	42 0.6×	25 0.5×	21	506

Countries citing papers authored by Shin‐ichi Yaguchi

Since Specialization

Citations

This map shows the geographic impact of Shin‐ichi Yaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin‐ichi Yaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin‐ichi Yaguchi more than expected).

Fields of papers citing papers by Shin‐ichi Yaguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin‐ichi Yaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin‐ichi Yaguchi. The network helps show where Shin‐ichi Yaguchi may publish in the future.

Co-authorship network of co-authors of Shin‐ichi Yaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Shin‐ichi Yaguchi. A scholar is included among the top collaborators of Shin‐ichi Yaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin‐ichi Yaguchi. Shin‐ichi Yaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Okamura, Mutsumi, Yuki Yoshimatsu, Tadashi Kondo, et al.. (2023). Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors. Cell Death and Disease. 14(2). 169–169. 5 indexed citations

Dan, Shingo, et al.. (2019). Abstract 3909: Potential antitumor effect of a pan-PI3K inhibitor ZSTK474 on human sarcoma cell lines. Cancer Research. 79(13_Supplement). 3909–3909. 1 indexed citations

Lockhart, A. Craig, Anthony J. Olszanski, Robin L. Allgren, et al.. (2013). Abstract B271: A first-in-human Phase I study of ZSTK474, an oral pan-PI3K inhibitor, in patients with advanced solid malignancies.. Molecular Cancer Therapeutics. 12(11_Supplement). B271–B271. 13 indexed citations

Haruta, Kazuhiko, Shigeyuki Mori, Naoto Tamura, et al.. (2012). Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats. Inflammation Research. 61(6). 551–562. 17 indexed citations

Anzai, Kazunori, Megumi Ueno, Mutsumi Okamura, et al.. (2011). Effectiveness of combined treatment using X‐rays and a phosphoinositide 3‐kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo. Cancer Science. 102(6). 1176–1180. 10 indexed citations

Kong, Dexin, Shin‐ichi Yaguchi, & Takao Yamori. (2009). Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor, on DNA-Dependent Protein Kinase. Biological and Pharmaceutical Bulletin. 32(2). 297–300. 47 indexed citations

Yaguchi, Shin‐ichi, Yasuhisa Fukui, Hisashi Yoshimi, et al.. (2006). Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor. JNCI Journal of the National Cancer Institute. 98(8). 545–556. 332 indexed citations

Yaguchi, Shin‐ichi, et al.. (1997). In Vitro Cytotoxicity of Imidazolyl-1,3,5-triazine Derivatives.. Biological and Pharmaceutical Bulletin. 20(6). 698–700. 21 indexed citations

Narita, Toshiharu, Yuji Koide, Shin‐ichi Yaguchi, et al.. (1991). Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine). Cancer Chemotherapy and Pharmacology. 28(4). 235–240. 19 indexed citations

10.

Narita, Toshiharu, Shin‐ichi Yaguchi, Toshihiko Komatsu, et al.. (1990). Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models. Cancer Chemotherapy and Pharmacology. 26(3). 193–197. 17 indexed citations

11.

Cai, Jun, Toshihiko Komatsu, Toshiyuki Matsuno, et al.. (1989). Synthesis and antitumor properties of N1-acyloxymethyl derivatives of bis(2,6-dioxopiperazines).. Chemical and Pharmaceutical Bulletin. 37(11). 2976–2983. 12 indexed citations

12.

Yaguchi, Shin‐ichi, et al.. (1984). Study on the contraction and oxygen consumption induced by high K,Na-deficient solution in the urinary bladder and gall bladder of guinea-pig.. The Japanese Journal of Pharmacology. 36(3). 407–412. 7 indexed citations

13.

Shimizu, Kazumasa, et al.. (1984). A Comparative Study on the Contraction Induced by High K/Na Deficient Solution in the Trachea, Gall Bladder and Urinary Bladder in Guinea-Pig. The Japanese Journal of Pharmacology. 34(2). 231–239. 2 indexed citations

14.

Shimizu, Kazumasa, et al.. (1984). A comparative study of the contraction induced by high K/Na deficient solution in the trachea, gall bladder and urinary bladder in guinea-pig.. The Japanese Journal of Pharmacology. 34(2). 231–239. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact